Cytogenetic Aberrations in Soft Tissue Tumors Harvested From Fresh Tissue Submitted for Surgical Pathology: A Single Institutional Experience

2009 ◽  
Vol 18 (4) ◽  
pp. 260-267
Author(s):  
Alisa Matthews ◽  
Mary Tang ◽  
Kumarasen Cooper
2016 ◽  
Vol 44 (4) ◽  
pp. 291-298 ◽  
Author(s):  
Shanna M. Colletti ◽  
Ghassan A. Tranesh ◽  
Chantel R. Whetsell ◽  
Larissa N. Chambers ◽  
Aziza Nassar

1991 ◽  
Vol 324 (7) ◽  
pp. 436-443 ◽  
Author(s):  
Jonathan A. Fletcher ◽  
Harry P. Kozakewich ◽  
Fredric A. Hoffer ◽  
Janice M. Lage ◽  
Noel Weidner ◽  
...  

Author(s):  
James S. Banks ◽  
Hillary W. Garner ◽  
Andrew Z. Chow ◽  
Jeffrey J. Peterson ◽  
Joseph M. Bestic ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (16) ◽  
pp. 4056
Author(s):  
Fiorella Calabrese ◽  
Francesco Fortarezza ◽  
Federica Pezzuto ◽  
Francesca Lunardi ◽  
Giovanni Comacchio ◽  
...  

The thymus is a specialized primary lymphoid organ located in the midline pre-vascular mediastinum. The organ is the site of various pathological processes, neoplastic and not, whose rarity has not allowed in-depth studies on clinical or histological features of rarest and unusual variants. Herein, we report a 10-year Padova experience in the surgical pathology of the thymus, focusing on the pathological description of nonneoplastic lesions and rare epithelial and mesenchymal tumors recorded in our database, which comprises over 600 thymectomies. The extrapolated rare cases have been categorized into four groups that included 15 cysts, 18 carcinomas, 5 neuroendocrine tumors, and 2 soft tissue tumors. The cases are described from a clinical and pathological point of view and discussed in dedicated sections with a review of the most important literature. In this case, review series, we aim to update the epidemiology of these rare entities, improve diagnostic awareness, and finally, promote a collaborative network between referral centers.


Author(s):  
D. C. Swartzendruber ◽  
Norma L. Idoyaga-Vargas

The radionuclide gallium-67 (67Ga) localizes preferentially but not specifically in many human and experimental soft-tissue tumors. Because of this localization, 67Ga is used in clinical trials to detect humar. cancers by external scintiscanning methods. However, the fact that 67Ga does not localize specifically in tumors requires for its eventual clinical usefulness a fuller understanding of the mechanisms that control its deposition in both malignant and normal cells. We have previously reported that 67Ga localizes in lysosomal-like bodies, notably, although not exclusively, in macrophages of the spocytaneous AKR thymoma. Further studies on the uptake of 67Ga by macrophages are needed to determine whether there are factors related to malignancy that might alter the localization of 67Ga in these cells and thus provide clues to discovering the mechanism of 67Ga localization in tumor tissue.


2020 ◽  
Vol 24 (06) ◽  
pp. 667-675
Author(s):  
Violeta Vasilevska Nikodinovska ◽  
Slavcho Ivanoski ◽  
Milan Samardziski ◽  
Vesna Janevska

AbstractBone and soft tissue tumors are a largely heterogeneous group of tumors. Biopsy of musculoskeletal (MSK) tumors is sometimes a challenging procedure. Although the open biopsy is still considered the gold standard for the biopsy of MSK lesions, core needle biopsy can replace it in most cases, with similar accuracy and a low complication rate. The biopsy should be performed in a tertiary sarcoma center where the multidisciplinary team consists of at minimum a tumor surgeon, an MSK pathologist, and an MSK radiologist who can assess all steps of the procedure. Several factors can influence the success of the biopsy including the lesion characteristics, the equipment, and the method used for the procedure. This review highlights some of the important aspects regarding the biopsy of the MSK tumors, with special attention to imaging a guided core needle biopsy and highlighting some of the recent advancements and controversies in the field.


Sign in / Sign up

Export Citation Format

Share Document